-
Clinical, Cosmetic and Investigational... 2024The available tools for evaluating scientific content target written scientific evidence and referencing without considering surgical, technical, or video graphic...
BACKGROUND
The available tools for evaluating scientific content target written scientific evidence and referencing without considering surgical, technical, or video graphic aspects.
OBJECTIVE
This study developed and validated a tool for qualitatively evaluating videos in the field of skin surgery. This will increase the quality of recorded surgical materials published online and ultimately enhance the reliability of streaming platforms as educational resources.
METHODOLOGY
Tool development included several stages: draft generation, expert panel setting, internal reliability testing, and pilot study.
RESULTS
After two rounds of expert panels evaluating the developed tool, 23 relevant items evaluating the educational value, scientific accuracy, and clarity of the surgical technical steps of the videos were obtained. We applied the tool to the top 25 YouTube videos discussing elliptical excision. Internal consistency, reliability, and substantial agreement between the raters were identified. We identified a strong positive correlation between our tool score and the global rating score (r= 0.55, P= 0.004).
CONCLUSION
It is critical to avoid relying on any video for educational purposes. The tool generated and validated in our study can determine a video's value. A pilot study of 25 YouTube videos demonstrated that the available videos are of fair-good quality, thus necessitating the need for high-quality video production.
PubMed: 38854851
DOI: 10.2147/CCID.S469592 -
Industrial Psychiatry Journal 2024Vitiligo is a common depigmenting dermatosis characterized by milky-white macules or patches. Any pathological discoloration of the skin has been linked to an impact on...
BACKGROUND
Vitiligo is a common depigmenting dermatosis characterized by milky-white macules or patches. Any pathological discoloration of the skin has been linked to an impact on the body image of an individual, and vitiligo has been linked to decreased self-esteem and poor socialization of the affected people. In Indian society, vitiligo is labeled as Shweta-Kushta (i.e., white-colored leprosy) and is compared to leprosy-a more stigmatizing skin condition.
AIM
This study aims to study gender-related differences in the quality of life of Indian vitiligo patients.
METHODOLOGY
In this hospital-based cross-sectional study, a total of 55 vitiligo patients (females 25 and males 30) were enrolled using the purposive sampling technique. The sample was assessed on Dermatology Life Quality Index (DLQI) questionnaire, Rosenberg Self-Esteem Scale (RSS), and General Health Questionnaire-12 (GHQ-12) to assess their quality of life, self-esteem, and psychological well-being, respectively. The gender differences in sociodemographic and clinical details as well as their relationship with the quality of life of the patients were sought with the help of appropriate statistical measures.
RESULTS
The patients of both genders were comparable in terms of all sociodemographic and clinical variables except the females being less educated and employed than the males. There was a statistically significant trend of higher mean DLQI total score in females than males (6.6 ± 3.55 vs 4.8 ± 2.71, Mann-Whitney U = 263.5, =0.058). Significantly, the average DLQI score in female vitiligo patients was negatively related to family income ( = -.659, <.001) and it was significantly higher for the patients from a rural background than those from an urban background (8.55 ± 3.30 vs 5.07 ± 3.03, Mann-Whitney U = 33.5, <.05). The average DLQI score was negatively correlated to RSS score but positively correlated to GHQ-12 score in patients of both genders.
CONCLUSION
The quality of life of female patients with vitiligo is poorer than the same in male patients. The poor financial condition of families and rural living are two factors related to the poorer quality of life of female patients. A poorer quality of life in vitiligo patients of both genders is linked with decreased self-esteem and decreased psychological well-being. Gender-related issues in the quality of life and the overall well-being of such patients are important in their management and policy-making.
PubMed: 38853817
DOI: 10.4103/ipj.ipj_74_23 -
Journal of the European Academy of... Jun 2024
PubMed: 38853646
DOI: 10.1111/jdv.20109 -
Journal of the American Academy of... Jun 2024
PubMed: 38851492
DOI: 10.1016/j.jaad.2024.05.078 -
Archives of Dermatological Research Jun 2024A knowledge gap exists regarding the association between vitiligo and rheumatoid arthritis (RA) due to the absence of large-scale cohort studies designed to investigate...
A knowledge gap exists regarding the association between vitiligo and rheumatoid arthritis (RA) due to the absence of large-scale cohort studies designed to investigate this association. To investigate the bidirectional epidemiological association between vitiligo and RA. A population-based study was conducted using Clalit Health Services (CHS) database (2002-2019) using both a cohort study and a case-control study design. Adjusted hazard ratio (HR) and odds ratio (OR) were calculated by multivariate Cox and logistic regressions, respectively. Overall, 20,851 vitiligo patients and 102,475 controls were included. The incidence of new-onset RA was 4.1 (95% CI 3.0-5.4) and 2.9 (95% CI 2.4-3.3) cases per 10,000 person-years among patients with vitiligo and controls, respectively. Patients with vitiligo had a significantly increased risk of developing new-onset RA (adjusted HR, 1.44; 95% confidence interval [CI], 1.02-2.02, P = 0.036). The likelihood of having vitiligo was significantly elevated after a preexisting diagnosis of RA (adjusted OR, 1.67; 95% CI, 1.38-2.03; P < 0.001). Relative to the remaining patients with vitiligo, those with vitiligo and comorbid RA demonstrated an elevated risk of all-cause mortality (adjusted HR, 1.61; 95% CI, 1.03-2.51; P = 0.037). Our study confirms the bidirectional association between vitiligo and RA. Physicians treating patients with vitiligo should be aware of the association in clinical practice.
Topics: Humans; Vitiligo; Arthritis, Rheumatoid; Female; Male; Middle Aged; Case-Control Studies; Adult; Incidence; Aged; Taiwan; Risk Factors; Databases, Factual
PubMed: 38850409
DOI: 10.1007/s00403-024-02965-7 -
Archives of Dermatological Research Jun 2024Loss and absence of melanocytes due to a number of factors is responsible for vitiligo; known to be the commonest disorder of pigmentation. The aim of the current work... (Randomized Controlled Trial)
Randomized Controlled Trial Comparative Study
Loss and absence of melanocytes due to a number of factors is responsible for vitiligo; known to be the commonest disorder of pigmentation. The aim of the current work was to compare the efficacy and safety of excimer light with topical tacrolimus ointment 0.1% versus excimer light with topical bimatoprost gel 0.01% in treatment of facial vitiligo. The study was carried out on 48 patients presented with facial vitiligo. The patients were divided randomly using sealed envelope method into two groups (24 patients each). Group 1 were treated with excimer light plus topical tacrolimus ointment 0.1% and group 2 treated with excimer light plus topical bimatoprost gel 0.01%. Clinical improvement based on the quartile grading scale at the end of treatment did not show any statistically significant difference between groups. The majority of subjects in both groups experienced good to excellent improvement. Only 20.9% of patients in group 1 and 33.3% of subjects in group 2 achieved less than 50% repigmentation (p = 0.889). Our study demonstrated that 0.01% topical bimatoprost gel in combination with excimer light is considered safe and effective as treatment of nonsegmental facial vitiligo with comparable results to 0.1% tacrolimus.
Topics: Humans; Vitiligo; Tacrolimus; Bimatoprost; Female; Male; Adult; Treatment Outcome; Young Adult; Adolescent; Middle Aged; Lasers, Excimer; Administration, Topical; Skin Pigmentation; Face; Administration, Cutaneous; Child; Combined Modality Therapy; Immunosuppressive Agents
PubMed: 38850408
DOI: 10.1007/s00403-024-03054-5 -
Archives of Dermatological Research Jun 2024Follicular cell suspension (FCS) transplantation is a novel surgical method for treating resistant stable vitiligo, whereas mini punch grafting is an established... (Comparative Study)
Comparative Study
Follicular cell suspension (FCS) transplantation is a novel surgical method for treating resistant stable vitiligo, whereas mini punch grafting is an established effective method for treating stable vitiligo. The combination of FCS and mini punch grafting is a better strategy for the treatment of resistant stable vitiligo. The aim of the study was to evaluate the efficacy of follicular cell suspension, mini punch grafting, and a combination of both techniques in the treatment of stable vitiligo. This prospective comparative study was conducted on 48 patients with stable vitiligo. They were divided into three equal groups, including group A (treated with follicular cell suspension), group B (treated with mini punch grafting), and group C (treated with the combination of both techniques). All patients were followed-up for six months for the assessment of their therapeutic response regarding clinical outcomes. By comparing the data of the three studied groups, we found that the difference in the degree of re-pigmentation after one and three months of treatment was not significant. However, the progress of re-pigmentation was significantly different after six months of treatment among the three studied groups (P = 0.027). Specifically, re-pigmentation was significantly better in group C than in groups A and B (P = 0.037 and 0.017, respectively), but it was not significantly different between groups A and B.
Topics: Humans; Vitiligo; Female; Male; Adult; Transplantation, Autologous; Prospective Studies; Treatment Outcome; Young Adult; Middle Aged; Adolescent; Skin Pigmentation; Hair Follicle; Skin Transplantation; Follow-Up Studies
PubMed: 38850293
DOI: 10.1007/s00403-024-03045-6 -
Indian Dermatology Online Journal 2024Vitiligo is an inveterate disease of great aesthetic concern presenting with depigmented macules and patches. It is often incorrigible to medical treatment.
BACKGROUND
Vitiligo is an inveterate disease of great aesthetic concern presenting with depigmented macules and patches. It is often incorrigible to medical treatment.
AIM
To study the clinical profile of vitiligo patients and evaluate the effect of 5% 5-fluorouracil (5-FU) cream with microneedling.
MATERIALS AND METHODS
This observational analytical study was conducted from November 2019 to July 2021. A total of 33 adult vitiligo patients were treated with oral mini-pulse (dexamethasone) therapy and topical corticosteroid (clobetasol propionate 0.05%). Patient's total number of vitiligo lesions with <10-cm size were counted and half of the lesions were treated with 5-FU + microneedling (Group A), while a remaining number of lesions were not treated with 5-FU + microneedling (Group B). In the case of the odd number of lesions, the total number of lesions minus one was considered and then divided into equal numbers for treatment. The procedure was performed every 2 weeks for 3 months. Clinical improvement was assessed monthly till 6 months by serial clinical photographs and grading scores.
RESULTS
Initiation of repigmentation started in the first month in Group A, whereas in Group B, it was seen in the second, which was statistically significant ( < 0.0001). Excellent improvement (>75% repigmentation) was noted in Group A as compared to Group B at the end of 6 months ( < 0.0001).
CONCLUSIONS
Needling with 5% 5-FU appears to be a simple, safe, and effective treatment in vitiligo. It can be used in poor responders to conventional therapy.
PubMed: 38845671
DOI: 10.4103/idoj.idoj_774_23 -
Indian Dermatology Online Journal 2024Vitiligo is an immune-mediated, chronic skin condition that affects both the innate and adaptive immune systems. Antimicrobial peptide overexpression is one of its...
BACKGROUND
Vitiligo is an immune-mediated, chronic skin condition that affects both the innate and adaptive immune systems. Antimicrobial peptide overexpression is one of its defining characteristics. Granulysin (GNLY), an antimicrobial peptide, may play a role in the pathogenesis of various autoimmune diseases.
OBJECTIVES
To estimate the serum GNLY levels in vitiligo patients and to correlate those levels with the severity and activity of the disease.
MATERIALS AND METHODS
This case-control study included 60 non-segmental vitiligo patients (Group A) and a control group of 60 people who were matched for age and sex, appeared to be in good health, and were not suffering from vitiligo (Group B). The serum granulysin levels of all subjects were measured using an enzyme-linked immunosorbent assay.
RESULTS
When compared to the control group, vitiligo patients had significantly higher serum GNLY levels ( = 0.001). When compared to patients with stable disease, those with active vitiligo had significantly higher serum GNLY levels ( = 0.008). Additionally, there was a positive correlation between the serum GNLY levels and the vitiligo area severity index and vitiligo disease activity scores ( = 0.004 and <0.001, respectively).
LIMITATIONS
Study population was relatively small. Evaluation of serum granulysin before and after treatment could have been more beneficial.
CONCLUSIONS
Blood granulysin levels could contribute to the pathogenesis of vitiligo. A higher serum granulysin level may also be a trustworthy predictor of the severity and progression of a disease.
PubMed: 38845658
DOI: 10.4103/idoj.idoj_386_23 -
International Journal of Dermatology Jun 2024
Black and Hispanic/Latino vitiligo patients experience a disproportionately elevated mental health burden: a cross-sectional analysis of a United States nationwide cohort.
PubMed: 38845133
DOI: 10.1111/ijd.17308